A Phase IIa Randomized, Double-Blind, Parallel-Groups, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of MK-0724 Intravenous Infusion on the Amelioration of Neurological Damage and Recovery from Middle Cerebral Artery Ischemic Stroke

  • Vaishnav, Anand (PI)
  • Dobbs, Michael (CoI)
  • Pettigrew, Luther (CoI)
  • Ryan, Stephen (CoI)

Grants and Contracts Details

Effective start/end date6/1/0711/30/10